Numerous mouse models of AD pathogenesis have been utilized to investigate the efficacy of tau antibodies for the treatment of AD, but few of these models recapitulated the concurrent tau and Aβ pathology observed in AD brains. The gene discussed is MAPT; the disease is Alzheimer disease.